Stock Report

Morepen Laboratories Ltd consolidated Q2FY22 PAT at Rs. 37.36 crore

Posted On : 2021-11-11 22:57:27( TIMEZONE : IST )

Morepen Laboratories Limited has reported Consolidated financial results for the period ended September 30, 2021.

Financial Results (Q2 FY2022) - QoQ Comparison

The company has reported total income of Rs. 398.1672 crores during the period ended September 30, 2021 as compared to Rs. 388.3133 crores during the period ended June 30, 2021.

The company has posted net profit / (loss) of Rs. 37.3637 crores for the period ended September 30, 2021 as against net profit / (loss) of Rs. 30.4741 crores for the period ended June 30, 2021.

The company has reported EPS of Rs. 0.72 for the period ended September 30, 2021 as compared to Rs. 0.59 for the period ended June 30, 2021.

Financials	Q2 FY2022	Q1 FY2022	% Change
Total Income	₹ 398.1672 crs	₹388.3133 crs	2.54%
Net Profit	₹37.3637 crs	₹30.4741 crs	22.61%
EPS	₹0.72	₹0.59	22.03%

Financial Results (Q2 FY2022) - YoY Comparison

The company has reported total income of Rs. 398.1672 crores during the period ended September 30, 2021 as compared to Rs.340.1285 crores during the period ended September 30, 2020.

The company has posted net profit / (loss) of Rs.37.3637 crores for the period ended September 30, 2021 as against net profit / (loss) of Rs.27.1690 crores for the period ended September 30, 2020.

The company has reported EPS of Rs.0.72 for the period ended September 30, 2021 as compared to Rs.0.60 for the period ended September 30, 2020.

Financials	Q2 FY2022	Q2 FY2021	% Change
Total Income	₹ 398.1672 crs	₹340.1285 crs	17.06%
Net Profit	₹37.3637 crs	₹27.1690 crs	37.52%
EPS	₹0.72	₹0.60	20.00%

Financial Results (Half Year Ended FY2022) - YoY Comparison

The company has reported total income of Rs.786.4805 crores during the 6 Months period ended September 30, 2021 as compared to Rs.599.0997 crores during the 6 Months period ended September 30, 2020.

The company has posted net profit / (loss) of Rs.67.8378 crores for the 6 Months period ended September 30, 2021 as against net profit / (loss) of Rs.46.5361 crores for the 6 Months period ended September 30, 2020.

The company has reported EPS of Rs.1.31 for the 6 Months period ended September 30, 2021 as compared to Rs.1.03 for the 6 Months period ended September 30, 2020.

Financials	Half Year Ended FY2022	Half Year Ended FY2021	% Change
Total Income	₹786.4805 crs	₹599.0997 crs	31.28%
Net Profit	₹67.8378 crs	₹46.5361 crs	45.77%
EPS	₹1.31	₹1.03	27.18%

Shares of Morepen Laboratories Limited was last trading in BSE at Rs. 50.85 as compared to the previous close of Rs. 51.20. The total number of shares traded during the day was 242941 in over 2172 trades.

The stock hit an intraday high of Rs. 51.85 and intraday low of 50.70. The net turnover during the day was Rs. 12448085.00.